Knowledge Management System of Northwest Institute of Plateau Biology, CAS
DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo | |
Li, Meng-yuan1,2,4; Lv, Yong-cong3; Tong, Lin-jiang2; Peng, Ting2; Qu, Rong2,4; Zhang, Tao4,5; Sun, Yi-ming2; Chen, Yi2; Wei, Li-xin1,4; Geng, Mei-yu2; Duan, Wen-hu3; Xie, Hua2; Ding, Jian2 | |
2016-03-01 | |
发表期刊 | ACTA PHARMACOLOGICA SINICA |
卷号 | 37期号:3页码:398-407 |
文章类型 | Article |
摘要 | Aim: Targeting the VEGF/VEGF receptor (VEGFR) pathway has proved to be an effective antiangiogenic approach for cancer treatment. Here, we identified 6-((2-((3-acetamidophenyl)amino)pyrimidin-4-yl)oxy)-N-phenyl-1-naphthamide (designated herein as DW10075) as a novel and highly selective inhibitor of VEGFRs. |
关键词 | Dw10075 Vegf/vegf Receptor Inhibitor Antitumor Angiogenesis U87-mg Human Glioblastoma |
WOS标题词 | Science & Technology ; Physical Sciences ; Life Sciences & Biomedicine |
DOI | 10.1038/aps.2015.117 |
关键词[WOS] | METASTATIC COLORECTAL-CANCER ; RENAL-CELL CARCINOMA ; ANGIOGENESIS INHIBITORS ; BEVACIZUMAB ; AXITINIB ; TARGETS ; KINASES ; POTENT |
收录类别 | SCI |
语种 | 英语 |
项目资助者 | National Natural Science Foundation of China(81173080 ; National Key Technology R&D Program of the Ministry of Science and Technology of China(2012BAI27B02) ; Research Program of Qinghai province(2012-T-Y23) ; 81321092 ; 81374063) |
WOS研究方向 | Chemistry ; Pharmacology & Pharmacy |
WOS类目 | Chemistry, Multidisciplinary ; Pharmacology & Pharmacy |
WOS记录号 | WOS:000371426900012 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://210.75.249.4/handle/363003/5766 |
专题 | 中国科学院西北高原生物研究所 |
作者单位 | 1.Chinese Acad Sci, Northwest Inst Plateau Biol, Pharmacol & Safety Evaluat Key Lab Tibetan Med Qi, Xining 810008, Peoples R China 2.Chinese Acad Sci, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China 3.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Dept Med Chem, Shanghai 201203, Peoples R China 4.Univ Chinese Acad Sci, Beijing 100049, Peoples R China 5.Shanghai Tech Univ, Shanghai 200120, Peoples R China |
推荐引用方式 GB/T 7714 | Li, Meng-yuan,Lv, Yong-cong,Tong, Lin-jiang,et al. DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo[J]. ACTA PHARMACOLOGICA SINICA,2016,37(3):398-407. |
APA | Li, Meng-yuan.,Lv, Yong-cong.,Tong, Lin-jiang.,Peng, Ting.,Qu, Rong.,...&Ding, Jian.(2016).DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo.ACTA PHARMACOLOGICA SINICA,37(3),398-407. |
MLA | Li, Meng-yuan,et al."DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo".ACTA PHARMACOLOGICA SINICA 37.3(2016):398-407. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论